Annual CFF
$74.54 M
+$46.85 M+169.18%
December 31, 2023
Summary
- As of February 7, 2025, APLT annual cash flow from financing activities is $74.54 million, with the most recent change of +$46.85 million (+169.18%) on December 31, 2023.
- During the last 3 years, APLT annual CFF has fallen by -$61.75 million (-45.31%).
- APLT annual CFF is now -45.31% below its all-time high of $136.29 million, reached on December 31, 2020.
Performance
APLT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
+$1.69 M+100.00%
September 30, 2024
Summary
- As of February 7, 2025, APLT quarterly cash flow from financing activities is $0.00, with the most recent change of +$1.69 million (+100.00%) on September 30, 2024.
- Over the past year, APLT quarterly CFF has dropped by -$16.57 million (-100.00%).
- APLT quarterly CFF is now -100.00% below its all-time high of $134.22 million, reached on March 31, 2020.
Performance
APLT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$143.25 M
-$16.57 M-10.37%
September 30, 2024
Summary
- As of February 7, 2025, APLT TTM cash flow from financing activities is $143.25 million, with the most recent change of -$16.57 million (-10.37%) on September 30, 2024.
- Over the past year, APLT TTM CFF has increased by +$99.09 million (+224.37%).
- APLT TTM CFF is now -24.87% below its all-time high of $190.66 million, reached on March 31, 2024.
Performance
APLT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
APLT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +169.2% | -100.0% | +224.4% |
| 3 y3 years | -45.3% | +100.0% | +81.3% |
| 5 y5 years | +179.7% | -100.0% | +153.9% |
APLT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.2% | +169.2% | -100.0% | +100.0% | -24.9% | >+9999.0% |
| 5 y | 5-year | -45.3% | +169.2% | -100.0% | +100.0% | -24.9% | >+9999.0% |
| alltime | all time | -45.3% | +1052.1% | -100.0% | +100.0% | -24.9% | >+9999.0% |
Applied Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $143.25 M(-10.4%) |
| Jun 2024 | - | -$1.69 M(-101.5%) | $159.82 M(-16.2%) |
| Mar 2024 | - | $115.50 M(+292.2%) | $190.66 M(+155.8%) |
| Dec 2023 | $74.54 M(+169.2%) | $29.45 M(+77.7%) | $74.54 M(+68.8%) |
| Sep 2023 | - | $16.57 M(-43.2%) | $44.16 M(+65.9%) |
| Jun 2023 | - | $29.15 M(-4786.7%) | $26.63 M(-4.4%) |
| Mar 2023 | - | -$622.00 K(-33.3%) | $27.86 M(+0.6%) |
| Dec 2022 | $27.69 M(-62.9%) | -$933.00 K(-3.9%) | $27.69 M(+0.9%) |
| Sep 2022 | - | -$971.00 K(-103.2%) | $27.44 M(+0.4%) |
| Jun 2022 | - | $30.39 M(-3951.1%) | $27.33 M(+6083.7%) |
| Mar 2022 | - | -$789.00 K(-33.4%) | $442.00 K(-99.4%) |
| Dec 2021 | $74.72 M | -$1.18 M(+9.6%) | $74.72 M(-5.4%) |
| Sep 2021 | - | -$1.08 M(-130.9%) | $78.99 M(+0.2%) |
| Jun 2021 | - | $3.50 M(-95.2%) | $78.84 M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $73.49 M(+2275.9%) | $75.56 M(-44.6%) |
| Dec 2020 | $136.29 M(+141.6%) | $3.09 M(-350.2%) | $136.29 M(-10.0%) |
| Sep 2020 | - | -$1.24 M(-667.0%) | $151.52 M(-0.6%) |
| Jun 2020 | - | $218.00 K(-99.8%) | $152.46 M(-18.8%) |
| Mar 2020 | - | $134.22 M(+632.6%) | $187.69 M(+232.7%) |
| Dec 2019 | $56.41 M(+111.7%) | $18.32 M(-6331.3%) | $56.41 M(-4.6%) |
| Sep 2019 | - | -$294.00 K(-100.8%) | $59.15 M(-0.5%) |
| Jun 2019 | - | $35.45 M(+1105.7%) | $59.47 M(+147.5%) |
| Mar 2019 | - | $2.94 M(-86.0%) | $24.03 M(-9.8%) |
| Dec 2018 | $26.65 M(+311.9%) | $21.06 M(>+9900.0%) | $26.65 M(+376.2%) |
| Sep 2018 | - | $28.00 K(+211.1%) | $5.60 M(+0.5%) |
| Jun 2018 | - | $9000.00(-99.8%) | $5.57 M(+0.2%) |
| Mar 2018 | - | $5.56 M | $5.56 M |
| Dec 2017 | $6.47 M | - | - |
FAQ
- What is Applied Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Applied Therapeutics?
- What is Applied Therapeutics annual CFF year-on-year change?
- What is Applied Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Applied Therapeutics?
- What is Applied Therapeutics quarterly CFF year-on-year change?
- What is Applied Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Applied Therapeutics?
- What is Applied Therapeutics TTM CFF year-on-year change?
What is Applied Therapeutics annual cash flow from financing activities?
The current annual CFF of APLT is $74.54 M
What is the all time high annual CFF for Applied Therapeutics?
Applied Therapeutics all-time high annual cash flow from financing activities is $136.29 M
What is Applied Therapeutics annual CFF year-on-year change?
Over the past year, APLT annual cash flow from financing activities has changed by +$46.85 M (+169.18%)
What is Applied Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of APLT is $0.00
What is the all time high quarterly CFF for Applied Therapeutics?
Applied Therapeutics all-time high quarterly cash flow from financing activities is $134.22 M
What is Applied Therapeutics quarterly CFF year-on-year change?
Over the past year, APLT quarterly cash flow from financing activities has changed by -$16.57 M (-100.00%)
What is Applied Therapeutics TTM cash flow from financing activities?
The current TTM CFF of APLT is $143.25 M
What is the all time high TTM CFF for Applied Therapeutics?
Applied Therapeutics all-time high TTM cash flow from financing activities is $190.66 M
What is Applied Therapeutics TTM CFF year-on-year change?
Over the past year, APLT TTM cash flow from financing activities has changed by +$99.09 M (+224.37%)